These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36001465)

  • 41. TLR4-dependent GM-CSF protects against lung injury in Gram-negative bacterial pneumonia.
    Standiford LR; Standiford TJ; Newstead MJ; Zeng X; Ballinger MN; Kovach MA; Reka AK; Bhan U
    Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(5):L447-54. PubMed ID: 22160309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae.
    Harada Y; Morinaga Y; Kaku N; Nakamura S; Uno N; Hasegawa H; Izumikawa K; Kohno S; Yanagihara K
    Clin Microbiol Infect; 2014 Nov; 20(11):O831-9. PubMed ID: 24813594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibacterial Activity of Human Simulated Epithelial Lining Fluid Concentrations of Ceftazidime-Avibactam Alone or in Combination with Amikacin Inhale (BAY41-6551) against Carbapenem-Resistant Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Almarzoky Abuhussain SS; Kuti JL; Nicolau DP
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29914950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In pursuit of the triple crown: mechanism-based pharmacodynamic modelling for the optimization of three-drug combinations against KPC-producing Klebsiella pneumoniae.
    Onufrak NJ; Smith NM; Satlin MJ; Bulitta JB; Tan X; Holden PN; Nation RL; Li J; Forrest A; Tsuji BT; Bulman ZP
    Clin Microbiol Infect; 2020 Sep; 26(9):1256.e1-1256.e8. PubMed ID: 32387437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunostimulatory Effect of Flagellin on MDR-
    van Linge CCA; Hulme KD; Peters-Sengers H; Sirard JC; Goessens WHF; de Jong MD; Russell CA; de Vos AF; van der Poll T
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice.
    Cao F; Wang X; Wang L; Li Z; Che J; Wang L; Li X; Cao Z; Zhang J; Jin L; Xu Y
    Biomed Res Int; 2015; 2015():752930. PubMed ID: 25879036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repurposing the anti-viral drug zidovudine (AZT) in combination with meropenem as an effective treatment for infections with multi-drug resistant, carbapenemase-producing strains of Klebsiella pneumoniae.
    DeSarno AE; Parcell BJ; Coote PJ
    Pathog Dis; 2020 Dec; 78(9):. PubMed ID: 33053176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiple Low Frequency Ultrasound Enhances Bactericidal Activity of Vancomycin against Methicillin-Resistant
    Wang J; Wen K; Liu X; Weng CX; Wang R; Cai Y
    Biomed Res Int; 2018; 2018():6023101. PubMed ID: 30364019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes.
    Sharma R; Patel S; Abboud C; Diep J; Ly NS; Pogue JM; Kaye KS; Li J; Rao GG
    Int J Antimicrob Agents; 2017 Feb; 49(2):224-232. PubMed ID: 28040408
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibacterial activity and carbapenem re-sensitizing ability of 1,10-phenanthroline-5,6-dione and its metal complexes against KPC-producing Klebsiella pneumoniae clinical strains.
    Vianez Peregrino I; Ferreira Ventura R; Borghi M; Pinto Schuenck R; Devereux M; McCann M; Souza Dos Santos AL; FerreiraNunes AP
    Lett Appl Microbiol; 2021 Aug; 73(2):139-148. PubMed ID: 33843058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitamin D Improves
    Hu JJ; Lin YS; Zhang JC; Wang YH
    Infect Drug Resist; 2024; 17():475-484. PubMed ID: 38348232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?
    Cojutti P; Sartor A; Bassetti M; Scarparo C; Pea F
    J Glob Antimicrob Resist; 2018 Sep; 14():238-241. PubMed ID: 29775786
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing
    Huang Y; Sokolowski K; Rana A; Singh N; Wang J; Chen K; Lang Y; Zhou J; Kadiyala N; Krapp F; Ozer EA; Hauser AR; Li J; Bulitta JB; Bulman ZP
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0069221. PubMed ID: 34152820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains.
    Erdem F; Abulaila A; Aktas Z; Oncul O
    Antimicrob Resist Infect Control; 2020 May; 9(1):70. PubMed ID: 32430058
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Yu W; Zhou K; Guo L; Ji J; Niu T; Xiao T; Shen P; Xiao Y
    Front Cell Infect Microbiol; 2017; 7():246. PubMed ID: 28670570
    [No Abstract]   [Full Text] [Related]  

  • 56. Triple combination of meropenem, colistin and tigecycline was bactericidal in a dynamic model despite mere additive interactions in chequerboard assays against carbapenemase-producing Klebsiella pneumoniae isolates.
    Tsala M; Vourli S; Georgiou PC; Pournaras S; Daikos GRL; Mouton JW; Meletiadis J
    J Antimicrob Chemother; 2019 Feb; 74(2):387-394. PubMed ID: 30376071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.
    Tängdén T; Hickman RA; Forsberg P; Lagerbäck P; Giske CG; Cars O
    Antimicrob Agents Chemother; 2014; 58(3):1757-62. PubMed ID: 24395223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic efficacy of beta-lactam and aminoglycoside antibiotics on experimental pneumonia caused by Klebsiella pneumoniae B-54 in diabetic mice.
    Obana Y; Nishino T; Tanino T
    J Antibiot (Tokyo); 1985 Jul; 38(7):941-7. PubMed ID: 3897162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ethanol feeding impairs innate immunity and alters the expression of Th1- and Th2-phenotype cytokines in murine Klebsiella pneumonia.
    Zisman DA; Strieter RM; Kunkel SL; Tsai WC; Wilkowski JM; Bucknell KA; Standiford TJ
    Alcohol Clin Exp Res; 1998 May; 22(3):621-7. PubMed ID: 9622442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Target Site Pharmacokinetics of Meropenem: Measurement in Human Explanted Lung Tissue by Bronchoalveolar Lavage, Microdialysis, and Homogenized Lung Tissue.
    Paal M; Scharf C; Denninger AK; Ilia L; Kloft C; Kneidinger N; Liebchen U; Michel S; Schneider C; Schröpf S; Schuster C; Vogeser M; Weinelt F; Zander J; Zoller M; Schroeder I
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0156421. PubMed ID: 34570645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.